COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments

The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk of complications from acquiring COVID-19 or treatment of high-risk patients who have a mild to moderate COVID-19 infection. Listen as Gregory Huhn, MD, MPHTM, discusses when and how to use monoclonal antibodies including:

• Bebtelovimab
• Cilgavimab/tixagevimab
• Sotrovimab

Presenter:

Gregory Huhn, MD, MPHTM
Associate Professor
Department of Infectious Diseases
Rush University Medical Center
Senior Director of HIV Services
Department of Infectious Diseases
Cook County Health
Chicago, Illinois

Review the downloadable slidesets at: 
https://bit.ly/3xOfu1A

Link to full program: 
https://bit.ly/3EBdf38

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.